## Core Concept
The management of bleeding esophageal and gastric varices primarily involves strategies to reduce portal pressure and control bleeding. This condition often arises in the context of liver cirrhosis and portal hypertension. Pharmacological and endoscopic interventions are key components of the initial management.

## Why the Correct Answer is Right
The correct answer, **Terlipressin**, is a synthetic analogue of vasopressin. It works by causing vasoconstriction of the splanchnic circulation, which reduces portal pressure and subsequently decreases blood flow to the varices, helping to control bleeding. Terlipressin is often used in conjunction with endoscopic therapy for acute variceal hemorrhage. It has a longer duration of action compared to vasopressin and is preferred for its efficacy and safety profile.

## Why Each Wrong Option is Incorrect
* **Option A:** This option is incorrect because, although not specified, common alternatives like octreotide (a somatostatin analogue) are used but terlipressin is specifically beneficial and recommended in guidelines for acute variceal bleeding.
* **Option B:** This option is incorrect as it is not specified but generally, drugs like propranolol are used for primary prophylaxis of variceal bleeding, not acute management.
* **Option C:** This option is incorrect as it likely refers to drugs not primarily used for acute variceal bleeding management.

## Clinical Pearl / High-Yield Fact
A key point to remember is that for acute variceal bleeding, the combination of vasoactive agents (like terlipressin) and endoscopic variceal ligation (EVL) or sclerotherapy is recommended as first-line treatment. This approach significantly improves outcomes by effectively controlling bleeding and reducing rebleeding rates.

## Correct Answer Line
**Correct Answer: D. Terlipressin**